← Back to library
Healthcare & Life Sciences

KSA PHARMA & MEDICAL DEVICES LOCALIZATION AND INVETSMENT : through 2027-2032

Pages
101
Format
PDF
Published
SEPTEMBER 2026

This report assesses where Saudi Arabia can build competitive local supply across pharmaceuticals and medical devices. It combines market demand, imports, buyer dynamics, regulation, pricing and procurement with value-chain analysis and localization screening across 14 product areas. Eight priority opportunities are assessed in greater depth through addressable market sizing, local-sales potential, CAPEX, reference-plant economics, returns, jobs, investor structures and partnership requirements. The report also examines Saudi competitiveness, supply-security considerations, risks and a phased pathway to investment decisions through 2027–2032

Key topics covered

  • •Saudi pharmaceutical and medical devices market outlook
  • •Healthcare demand, buyers and procurement landscape
  • •Pharmaceutical and medical device import dependency
  • •Supply security and localization priorities
  • •SFDA regulation, pricing and market access
  • •NUPCO procurement and local-content requirements
  • •Pharma and medical device value chains
  • •14 localization opportunity areas
  • •Eight priority investment opportunities
  • •Reference-plant CAPEX, returns, payback and jobs
  • •Technology transfer, partnerships and investor structures
  • •Saudi manufacturing competitiveness and landed-cost economics
  • •Investment incentives, financing and bankability
  • •Future scenarios, risks and 12-month investment roadmap

Key questions addressed

  • •How large are Saudi Arabia’s pharmaceutical and medical device markets?
  • •How credible is the current localization and manufacturing base?
  • •Which pharmaceutical and medical device products should be localized first?
  • •Which opportunities belong in Wave 1, Wave 2 or strategic supply-security platforms?
  • •How large is the addressable localization opportunity through 2027–2032?
  • •What CAPEX, revenues, returns and jobs, potential IRR could individual manufacturing projects generate?
  • •Which opportunities require multi-year procurement commitments or additional government support?
  • •Which technology partners and investment structures are best suited to each opportunity?
  • •Can Saudi-made products compete with imports on cost, quality and market access?
  • •What actions are required to reach an investment decision within 12 months?

Table of contents

  • Executive Summary
  • Global Market
  • Saudi Demand & Supply
  • Regulation, Pricing and Procurement
  • Value Chain and Localization Landscape
  • Localization Opportunities
  • Investor Strategy
  • Competitiveness
  • Scenarios, Risks and Next Plans

Selected preview pages

KSA PHARMA & MEDICAL DEVICES LOCALIZATION AND INVETSMENT : through 2027-2032 cover

Purchase options

Account required